Research
Birch leaf for Bladder Health: Evidence, Interactions and Cautions
Birch leaf is an ingredient used in bladder supplements marketed to women. Below is what it has actually been studied for, how strong that evidence is, the drug interactions and cautions on record, and the primary source our grade rests on — all drawn from the HerWellReport ingredient dataset.
Also sold as: Betula pendula; Betula pubescens; Betulae folium; silver birch leaf
What the evidence says about Birch leaf
The EMA's public summary is explicit that the approval rests on traditional use rather than trials: the data are too limited to be used as evidence, and the only clinical study it cites is one of 15 patients with urinary tract infections. The committee judged the effect plausible on the basis of at least 30 years of documented use, 15 of them in the EU. A flushing effect is not the same as treating an infection.
The grade "traditional" means: traditional — A long history of use but little or no human trial evidence for this outcome. Grades are explained in full on our methodology page.
Read the primary source this grade rests on (opens in a new tab).
Birch leaf drug interactions
No documented drug interactions in the sources we checked. That is not the same as proof of safety alongside your medication — it usually means the question has not been studied. Ask a pharmacist before combining it with prescription drugs.
Who should be careful with Birch leaf
- Not if you are allergic to birch leaf or birch pollen
- Not if you have been told to restrict fluids, for example in severe heart or kidney disease
- Not under 12 years
- Use for 2 to 4 weeks only
Read more on HerWellReport
This entry is generated from row "Birch leaf" of the HerWellReport ingredient dataset (v2.1, updated 2026-09-23). The dataset is free to reuse under CC BY 4.0 — how to cite it. Ingredient evidence is not evidence for any finished product, and nothing here is medical advice.